Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Current Diabetes Reviews|November 12, 2010
Estrogens and progression of diabetic kidney damageSophie Doublier, Enrico Lupia, Paola Catanuto, et al.
Chest|April 24, 2021
Stem Cell Therapy for COPD: Hope and ExploitationMarilyn K Glassberg, Isabelle Csete, Emmanuelle Simonet, et al.
Clinics in Geriatric Medicine|October 10, 2017
Lung Diseases of the Elderly: Cellular MechanismsKori Ascher, Sharon J Elliot, Gustavo A Rubio, et al.
The American Journal of Pathology|August 1, 2006
Differential effects of continuous and intermittent 17beta-estradiol replacement and tamoxifen therapy on the prevention of glomerulosclerosis: modulation of the mesangial cell phenotype in vivoMichael Karl, Mariana Berho, Judith Pignac-Kobinger, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 14, 2003
Response to sex hormones differs in atherosclerosis-susceptible and -resistant miceMylène Potier, Michael Karl, Sharon J Elliot, et al.
Surgery|November 13, 2017
Estrogen receptor subtype expression and regulation is altered in papillary thyroid cancer after menopauseGustavo A Rubio, Paola Catanuto, Marilyn K Glassberg, et al.
The American Journal of Pathology|May 10, 2002
Estrogen-related abnormalities in glomerulosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogensMylène Potier, Michael Karl, Feng Zheng, et al.
Endocrinology|March 25, 2006
Low insulin-like growth factor binding protein-2 expression is responsible for increased insulin receptor substrate-1 phosphorylation in mesangial cells from mice susceptible to glomerulosclerosisAlessia Fornoni, Steven A Rosenzweig, Oliver Lenz, et al.
Diabetes|January 5, 2002
Autocrine activation of the IGF-I signaling pathway in mesangial cells isolated from diabetic NOD miceIvan Tack, Sharon J Elliot, Mylene Potier, et al.
Endocrinology|November 20, 2004
Autocrine activation of the local insulin-like growth factor I system is up-regulated by estrogen receptor (ER)-independent estrogen actions and accounts for decreased ER expression in type 2 diabetic mesangial cellsMichael Karl, Mylene Potier, Ivonne H Schulman, et al.
Pageof 4